INCYTE CORP

INCY Nasdaq CIK: 0000879169

Company Information

Industry Services-Commercial Physical & Biological Research
SIC Code 8731
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Mailing Address 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Phone 3024986700
Fiscal Year End 1231
EIN 943136539

Financial Overview

FY2025

$6.96B
Total Assets
$2.00B
Total Liabilities
$3.10B
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 30, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
4 Insider stock transaction report March 26, 2026 View on SEC
8-K Current report of material events March 26, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
8-K Current report of material events March 6, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment February 10, 2026 View on SEC
8-K Current report of material events February 10, 2026 View on SEC
10-K Annual financial report February 10, 2026 View on SEC

Material Events

8-K Other March 6, 2026
High Impact
  • Zynyz® approval for metastatic NSCLC delayed by FDA due to manufacturing issues at a third-party facility, not drug efficacy or safety.
  • The drug demonstrated positive Phase 3 results (POD1UM-304), meeting its primary endpoint with statistically significant overall survival improvement.
View Analysis

Insider Trading

STRONG SELL 6 insiders 13 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8731)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.